About: Circulating serum levels of IL-1ra in patients with relapsing remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to IFN-beta treatment

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Circulating serum levels of IL-1ra in patients with relapsing remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to IFN-beta treatment Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 May 1996

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 1996 (uk) im Mai 1996 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en mayu de 1996 (ast) scientific article published on 01 May 1996 (en)
publication date	wds:Q71311050-43571694-280D-4A5F-B623-4B9C9A8CA52C
publication date	1996-05-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q71311050-2283B031-17BD-421F-8862-6E76494F092A wds:Q71311050-3BB9034F-BA7A-4423-8921-7D067FCF8B82 wds:Q71311050-97488205-35AD-4958-BB6C-057D4676ECAE wds:Q71311050-99DA878E-48DD-423D-A2C2-2A7D5B76EBB2 wds:Q71311050-9D6D1920-7E8A-45D3-9B2D-876C8BA47E71 wds:Q71311050-FC64EFA5-2FA4-4908-BDD5-C44047FC95BF
author name string	Patti F Nicoletti A Reggio A Nicoletti F Zaccone P DiMarco R
rdfs:label	Circulating serum levels of IL-1ra in patients with relapsing remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to IFN-beta treatment (en) Circulating serum levels of IL-1ra in patients with relapsing remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to IFN-beta treatment (nl)
skos:prefLabel	Circulating serum levels of IL-1ra in patients with relapsing remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to IFN-beta treatment (en) Circulating serum levels of IL-1ra in patients with relapsing remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to IFN-beta treatment (nl)
name	Circulating serum levels of IL-1ra in patients with relapsing remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to IFN-beta treatment (en) Circulating serum levels of IL-1ra in patients with relapsing remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to IFN-beta treatment (nl)
author	wds:Q71311050-7621DCF9-3687-4D8A-B079-EFCDA9075915 wds:Q71311050-D4588519-EF07-4456-B437-74B85A010EFE
author	Pier Luigi Meroni Ferdinando Nicoletti
title	wds:Q71311050-2D1BAC73-651B-4D7A-9DB2-7FAECD1A8972
title	Circulating serum levels of IL-1ra in patients with relapsing remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to IFN-beta treatment (en)
page(s)	wds:Q71311050-C73A7257-FA1A-4E8C-8178-37395B9DA9E8
page(s)	395-400
instance of	wds:Q71311050-1BA004E6-7BAC-4099-A661-8E8345FBCE8A
instance of	scholarly article
main subject	wds:Q71311050-6C84FB3B-76C1-47E5-B01C-D4D64A1A0F74 wds:Q71311050-DDA81028-DBDF-431F-8BD2-913E845231FA
main subject	anakinra multiple sclerosis
PubMed ID	wds:Q71311050-9136657F-75AE-41E6-B3EA-F6DB658259F6
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8726668
PubMed ID	8726668
published in	wds:Q71311050-01C8E4F5-F1C8-46B9-AE83-8B051AFCBA05
published in	Cytokine
issue	wds:Q71311050-14F054DA-15E0-448E-A5EF-A80B865E25C2
volume	wds:Q71311050-A4AB107B-D193-4109-AC22-91462B643460
issue	5
volume	8
DOI	wds:Q71311050-6AFC72F9-5BC2-4AFC-A613-B944B757CF73
DOI	http://dx.doi.org/10.1006/CYTO.1996.0054
DOI	10.1006/CYTO.1996.0054
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q71311050
is cites work of	The IL-1 family: regulators of immunity Therapeutic potential of carbon monoxide in multiple sclerosis Blood levels of transforming growth factor-beta 1 (TGF-beta1) are elevated in both relapsing remitting and chronic progressive multiple sclerosis (MS) patients and are further augmented by treatment with interferon-beta 1b (IFN-beta1b). Interferon beta stimulates interleukin 1 receptor antagonist production in human articular chondrocytes and synovial fibroblasts Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1beta in human monocytes and multiple sclerosis. Cytokines in autoimmunity Association of two variants in IL-1beta and IL-1 receptor antagonist genes with multiple sclerosis NLRP3 Inflammasome and MS/EAE. Interleukin 1 receptor antagonist (IL-1ra) in multiple sclerosis Gene expression changes in multiple sclerosis relapse suggest activation of T and non-T cells Induction of serum soluble tumor necrosis factor receptor II (sTNF-RII) and interleukin-1 receptor antagonist (IL-1ra) by interferon beta-1b in patients with progressive multiple sclerosis. Interferon-β treatment in multiple sclerosis patients decreases the number of circulating T cells producing interferon-γ and interleukin-4 Increased IL-13 but not IL-5 production by CD4-positive T cells and CD8-positive T cells in multiple sclerosis during relapse phase New Insights into the Role of IL-1β in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis Interleukin-1β and interleukin-1 receptor antagonist appear in grey matter additionally to white matter lesions during experimental multiple sclerosis Production of IL-1beta and IL-1Ra as risk factors for susceptibility and progression of relapse-onset multiple sclerosis Interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms in Greek multiple sclerosis (MS) patients with bout-onset MS. Th1, Th2, and Th17 Cytokine Involvement in Thyroid Associated Ophthalmopathy NLR-Dependent Regulation of Inflammation in Multiple Sclerosis- Dependent Regulation of Inflammation in Multiple Sclerosis. Human periodontal ligament stem cells secretome from multiple sclerosis patients suppresses NALP3 inflammasome activation in experimental autoimmune encephalomyelitis. Upregulation of IL-1 Receptor Antagonist in a Mouse Model of Migraine Global methylation correlates with clinical status in multiple sclerosis patients in the first year of IFNbeta treatment Interleukin (IL)-1 gene polymorphisms: relevance of disease severity associated alleles with IL-1beta and IL-1ra production in multiple sclerosis In Silico and In Vivo Analysis of IL37 in Multiple Sclerosis Reveals Its Probable Homeostatic Role on the Clinical Activity, Disability, and Treatment with Fingolimod DFMG attenuates the activation of macrophages induced by co‑culture with LPC‑injured HUVE‑12 cells via the TLR4/MyD88/NF‑κB signaling pathway. Interleukin-37: A crucial cytokine with multiple roles in disease and potentially clinical therapy. IFNβ and glatiramer acetate trigger different signaling pathways to regulate the IL-1 system in multiple sclerosis
is cites work of	wds:Q26999245-123F9C25-6BD0-496F-B599-B23B12D7A1D8 wds:Q34500740-CBC3CCF2-2039-405F-9531-8C101A410B9B wds:Q64944469-E1C990A8-5616-45BA-9758-773E48E18DF7 wds:Q73800880-FE12885D-46DE-45CD-B079-8FA9FB7010F9 wds:Q92084391-0C46901E-127E-4A54-ADAE-1B1BD915AC1B wds:Q36566053-27F0609F-EE99-4A56-9D04-E1C80A8AF5DA wds:Q38617905-06F6A002-B552-42AD-AD2D-91971F8DC784 wds:Q41312485-5C008F4E-AD02-4639-847B-951B948C2729 wds:Q57267967-E2DDB847-6200-42C4-B81B-6A798A4B1CA3 wds:Q49516622-04385AB4-6774-4C08-9D40-B424F87A2BB9 wds:Q37114231-B0BCE405-FA51-4066-A934-BB61D99300A7 wds:Q37676929-F0E4BB4A-4DA2-4FDF-A3F1-ADD0CDE1426F wds:Q52649775-45DCDD30-3222-43D5-88E9-B1D618A9900D wds:Q51886341-87374B0E-69B0-45FD-9CA1-BABCAC499713 wds:Q92154588-7D8229C6-E13B-4BEF-AE99-9E448CA2B349 wds:Q35553245-9BA71C06-EFE2-421A-AA01-67E56FDEA11D wds:Q34775525-C5099C36-CB8C-46C9-B613-B30B908B68BB wds:Q52684068-A67C83CD-F297-46F0-803D-525E8BB186D6 wds:Q50318208-A3742349-5685-4B19-A61D-6698A0C02248 wds:Q73539375-913865D7-59FF-4487-8F04-5B60B6E9FD3B

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software